These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35881912)

  • 41. Ugi Four-Component Reactions Using Alternative Reactants.
    Hooshmand SE; Zhang W
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicomponent reactions are accelerated in water.
    Pirrung MC; Sarma KD
    J Am Chem Soc; 2004 Jan; 126(2):444-5. PubMed ID: 14719923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multicomponent Reactions in the Synthesis of Antiviral Compounds.
    Botta L; Cesarini S; Zippilli C; Bizzarri BM; Fanelli A; Saladino R
    Curr Med Chem; 2022; 29(12):2013-2050. PubMed ID: 34620058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereoselective Synthesis of Functionalized Bicyclic Scaffolds by Passerini 3-Center-2-Component Reactions of Cyclic Ketoacids.
    Cioc RC; Estévez V; van der Niet DJ; Vande Velde CM; Turrini NG; Hall M; Faber K; Ruijter E; Orru RV
    European J Org Chem; 2017 Mar; 2017(9):1262-1271. PubMed ID: 28344504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ugi and Passerini reactions of biocatalytically derived chiral aldehydes: application to the synthesis of bicyclic pyrrolidines and of antiviral agent telaprevir.
    Moni L; Banfi L; Basso A; Carcone L; Rasparini M; Riva R
    J Org Chem; 2015 Apr; 80(7):3411-28. PubMed ID: 25801330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ionic polysaccharide hydrogels via the Passerini and Ugi multicomponent condensations: synthesis, behavior and solid-state NMR characterization.
    de Nooy AE; Capitani D; Masci G; Crescenzi V
    Biomacromolecules; 2000; 1(2):259-67. PubMed ID: 11710109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the direct use of CO
    Onwukamike KN; Grelier S; Grau E; Cramail H; Meier MAR
    RSC Adv; 2018 Sep; 8(55):31490-31495. PubMed ID: 35548239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploitation of the Ugi-Joullié reaction in drug discovery and development.
    Gazzotti S; Rainoldi G; Silvani A
    Expert Opin Drug Discov; 2019 Jul; 14(7):639-652. PubMed ID: 31002536
    [No Abstract]   [Full Text] [Related]  

  • 49. Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.
    Fouad MA; Abdel-Hamid H; Ayoup MS
    RSC Adv; 2020 Nov; 10(70):42644-42681. PubMed ID: 35514898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Catalytic Enantioselective Ugi Four-Component Reactions.
    Shaabani S; Dömling A
    Angew Chem Int Ed Engl; 2018 Dec; 57(50):16266-16268. PubMed ID: 30431219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating Ugi/Passerini Multicomponent Reactions for the Site-Selective Conjugation of Native Trastuzumab*.
    Sornay C; Hessmann S; Erb S; Dovgan I; Ehkirch A; Botzanowski T; Cianférani S; Wagner A; Chaubet G
    Chemistry; 2020 Nov; 26(61):13797-13805. PubMed ID: 32588934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of N-acyl-N,alpha,alpha-trialkyl and N-acyl-alpha,alpha-dialkyl glycines by selective cleavage of Ugi-Passerini adducts. Qualitative assessment of the effect of substituents on the path and yield of reaction.
    Jiang WQ; Costa SP; Maia HL
    Org Biomol Chem; 2003 Nov; 1(21):3804-10. PubMed ID: 14649912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An improved approach for the synthesis of alpha,alpha-dialkyl glycine derivatives by the Ugi-Passerini reaction.
    Costa SP; Maia HL; Pereira-Lima SM
    Org Biomol Chem; 2003 May; 1(9):1475-9. PubMed ID: 12926275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Unprecedented Retro-Mumm Rearrangement Revealed by ESI-MS/MS, IRMPD Spectroscopy, and DFT Calculations.
    Iacobucci C; Reale S; Aschi M; Oomens J; Berden G; De Angelis F
    Chemistry; 2018 May; 24(27):7026-7032. PubMed ID: 29517821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OPHA (oxidation-Passerini-hydrolysis-alkylation) strategy: a four-step, one-pot improvement of the alkylative Passerini reaction.
    De Moliner F; Bigatti M; Banfi L; Riva R; Basso A
    Org Lett; 2014 Apr; 16(8):2280-3. PubMed ID: 24720585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facile Synthesis of In-Chain, Multicomponent, Functionalized Polymers via Living Anionic Copolymerization through the Ugi Four-Component Reaction (Ugi-4CR).
    Shen H; Ma H; Liu P; Huang W; Han L; Li C; Li Y
    Macromol Rapid Commun; 2017 Sep; 38(18):. PubMed ID: 28759143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the chemistry and reactivity of alpha-substituted ketones in isonitrile-based multicomponent reactions.
    Fan L; Adams AM; Polisar JG; Ganem B
    J Org Chem; 2008 Dec; 73(24):9720-6. PubMed ID: 18939871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of Passerini-3CR Polymers and Assembly into Cytocompatible Polymersomes.
    Travanut A; Monteiro PF; Oelmann S; Howdle SM; Grabowska AM; Clarke PA; Ritchie AA; Meier MAR; Alexander C
    Macromol Rapid Commun; 2021 Mar; 42(6):e2000321. PubMed ID: 33249682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New oxacycles on the block: benzodioxepinones via a Passerini reaction.
    Fragkiadakis M; Zingiridis M; Loukopoulos E; Neochoritis CG
    Mol Divers; 2024 Feb; 28(1):29-35. PubMed ID: 35900638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FormylBODIPYs: Privileged Building Blocks for Multicomponent Reactions. The Case of the Passerini Reaction.
    Ramírez-Ornelas DE; Alvarado-Martínez E; Bañuelos J; López Arbeloa I; Arbeloa T; Mora-Montes HM; Pérez-García LA; Peña-Cabrera E
    J Org Chem; 2016 Apr; 81(7):2888-98. PubMed ID: 26966917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.